Anaplastic Astrocytoma - Pharmaceuticals and Healthcare
Latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Astrocytoma - Pipeline Review, H2 2017, provides an overview of the Anaplastic astrocytoma(Oncology) pipeline landscape.
Anaplastic astrocytoma is a grade III tumor. It accounts for
two percent of all brain tumors. It is a type of glioma that develops from
star-shaped glial cells (astrocytes), which support nerve cells. Anaplastic
astrocytoma grows faster and more aggressively than grade II astrocytomas.
The tumor cells are not uniform in appearance and invade
neighboring tissue. Symptoms include a headache, weakness, clumsiness,
difficulty walking and seizures. Anaplastic astrocytoma is common among men and
women in their thirties to fifties and is more common in men than women.
Treatment of anaplastic astrocytoma depends on the location of the tumor and
how far it has progressed and usually involves surgery and radiation therapy,
with chemotherapy during or following radiation.
Related
Reports:
Anaplastic
Thyroid Cancer - Pipeline Insight, 2017
Contact
Details:
Aarkstore
Enterprise
Phone: +91 - 22 2756 4963
24/7 Online Support: +91 9987295242
Email: enquiry@aarkstore.com
Our website: http://www.aarkstore.com
Our blog: http://www.aarkstore.com/blog/
Phone: +91 - 22 2756 4963
24/7 Online Support: +91 9987295242
Email: enquiry@aarkstore.com
Our website: http://www.aarkstore.com
Our blog: http://www.aarkstore.com/blog/
Comments
Post a Comment